A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections
Titel:
A phase III, multicenter, double-blind, randomized clinical trial to evaluate the efficacy and safety of ceftolozane/tazobactam plus metronidazole versus meropenem in Chinese participants with complicated intra-abdominal infections
Auteur:
Sun, Yihong Fan, Jia Chen, Gang Chen, Xiaofei Du, Xiaoling Wang, Ye Wang, Hui Sun, Fang Johnson, Matthew G. Bensaci, Mekki Huntington, Jennifer A. Bruno, Christopher J.
Verschenen in:
International journal of infectious diseases
Paginering:
Jaargang 123 () nr. C pagina's 157-165
Jaar:
2022
Inhoud:
Uitgever:
Merck Sharp & Dohme LLC., a subsidiary Merck & Co., Inc.,, The Author(s).